1. Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study. Issue 1 (5th May 2012) Authors: Kavanaugh, Arthur; Fleischmann, Roy M; Emery, Paul; Kupper, Hartmut; Redden, Laura; Guerette, Benoit; Santra, Sourav; Smolen, Josef S Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 1(2013) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗